Incidence of hepatitis B reactivation following Rituximab therapy

Am J Hematol. 2009 Mar;84(3):195. doi: 10.1002/ajh.21343.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / adverse effects*
  • Hepatitis B, Chronic / epidemiology*
  • Hepatitis B, Chronic / immunology
  • Humans
  • Incidence
  • Michigan / epidemiology
  • Retrospective Studies
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab